Tag: GlaxoSmithKline
-
Is the GlaxoSmithKline share price a bargain or should I buy this high-yielding small-cap?
Does this small-cap share’s recovery potential outshine the forward prospects of GlaxoSmithKline plc (LON: GSK)? More »
-
GSK and Sopheon’s share prices have beaten the FTSE 100 by 20%, is it time to buy?
Do GlaxoSmithKline plc (LON: GSK) and Sopheon plc (LON: SPE) offer further FTSE 100 (INDEXFTSE: UKX) outperformance potential? More »
-
Is this FTSE 250 faller set to bounce back and crush the GSK share price?
The GlaxoSmithKline plc (LON: GSK) share price has climbed in 2018, but here's one that could beat it in 2019. More »
-
FTSE 100 dividend stock GlaxoSmithKline isn’t the only healthcare star that could help you retire rich
Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is just one London-quoted healthcare stock that could make you rich. More »
-
GlaxoSmithKline isn’t the only way to profit from the world’s ageing population
Edward Sheldon looks at a stock which, alongside GlaxoSmithKline plc (LON: GSK), could be set to benefit from the explosion in retirees across the... More »
-
3 FTSE 100 dividend stocks yielding 5%+ I’d buy for a new SIPP
Roland Head reveals his three top FTSE 100 (INDEXFTSE:UKX) picks for a starter pension portfolio. More »
-
Is the GSK share price primed to beat the FTSE 100?
Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)? More »
-
GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now
Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm. More »
-
A soaring growth candidate plus a FTSE 100 dividend stock I’d buy today
Do you go for growth investing or do you seek dividend income? Here are two stocks that could deliver a combination of both. More »
-
Build a second income stream with these 2 terrific FTSE 100 dividend stocks
Royston Wild takes a look at two FTSE 100 (INDEXFTSE: UKX) dividend stars that could make you rich. More »
-
3 top FTSE 100 dividend stocks I’m buying right now
Rupert Hargreaves highlights his three favourite FTSE 100 (INDEXFTSE: UKX) dividend stocks. More »
-
Here’s why the GSK share price could climb while Spire Healthcare sinks by 20%+
GlaxoSmithKline plc (LON: GSK) appears to offer better investment potential than Spire Healthcare plc (LON: SPI). More »
-
Here’s why the GSK share price could be set to beat the FTSE 100
GlaxoSmithKline plc (LON: GSK) shares have been lagging the FTSE 100, but could 2018's comeback mark a new upward trend? More »
-
How did FTSE 100 dividend stock GlaxoSmithKline get to be so risky?
Harvey Jones hopes FTSE 100 (INDEXFTSE: UKX) income stalwart GlaxoSmithKline plc (LSE: GSK) can pull off its tricky balancing act. More »
-
Is GlaxoSmithKline a high-yield dividend star or a dangerous dog of the FTSE 100?
How sustainable is the GlaxoSmithKline plc (LON: GSK) dividend? More »
-
GlaxoSmithKline isn’t the only high yield pharma stock I’d buy today
GlaxoSmithKline plc (LON: GSK) isn't the only white-hot dividend stock lurking in the pharmaceuticals space. More »
-
My 3 favourite FTSE 100 5% yielders
Rupert Hargreaves shares his three favourite FTSE 100 (INDEXFTSE: UKX) income stocks and he thinks they have growth potential. More »
-
How I’m building a second income with high yielders GSK and Royal Dutch Shell
Edward Sheldon explains how he collects regular dividend cheques from Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK). More »
-
Why the GSK share price should smash the FTSE 100 this year
Roland Head takes a look at FTSE 100 (INDEXFTSE:UKX) climber GlaxoSmithKline plc (LON:GSK) and highlights another turnaround opportunity. More »
-
Is GSK’s share price the Footsie bargain of 2018?
Does GlaxoSmithKline plc (LON: GSK) offer a potent risk/reward ratio for the long term? More »